Results 151 to 160 of about 9,727 (175)

Efficacy of Urate–Lowering Therapy in Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials

Clinical Therapeutics, 2022
Yu Xiang, Mingjia Gu
exaly  

Safety of Urate-Lowering Therapies

Rheumatic Disease Clinics of North America, 2012
openaire   +1 more source

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

New England Journal of Medicine, 2020
Alessandro Doria, Cathie Spino, Rodica Pop-Busui   +2 more
exaly  

Cardiovascular diseases in gout and urate-lowering therapy

Therapy, 2021
openaire   +1 more source

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy

Joint Bone Spine, 2020
Tristan Pascart, Augustin Latourte, Gérard Chalès   +2 more
exaly  

Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort

Joint Bone Spine, 2022
Shuhui Hu, Robert Terkeltaub, Mingshu Sun   +2 more
exaly  

Response to “Urate lowering therapy for patients with gout on hemodialysis”

International Journal of Rheumatic Diseases, 2022
Reem Alkilany, Douglas Einstadter, Maria Antonelli   +2 more
openaire   +2 more sources

Urate-Lowering Therapy

2017
openaire   +1 more source

When to Start Urate Lowering Therapy?

Egyptian Journal of Rheumatology and Clinical Immunology, 2015
openaire   +1 more source

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial

Lancet, The, 2018
Michael Doherty, Aliya Sarmanova, Abhishek Abhishek   +2 more
exaly